The objections surrounding the use of embryonic stem cells in organ and tissue reconstruction could be silenced if clinical trials for a new strain of stem cells derived from liposuctioned fat get a nod of approval from the FDA. And if they do, their first order of business will probably be growing bigger breasts.
Trending Articles
More Pages to Explore .....